Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

81.13 +0.25 (+0.31%)
Official Closing Price Updated: 7:00 PM EST, Dec 2, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,366,705
Open 80.37
Bid (Size) 80.41 (2)
Ask (Size) 81.12 (2)
Prev. Close 80.88
Today's Range 80.37 - 81.16
52wk Range 54.67 - 81.44
Shares Outstanding 2,222,113,553
Dividend Yield 2.42%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's session, 108 stocks hit new 52-week highs. 
Via Benzinga
The Top Healthcare Stocks to Buy With $100
Triple-digit growth and innovation go hand-in-hand with these companies. 
Via The Motley Fool

Performance

YTD
+31.11%
+31.11%
1 Month
+4.75%
+4.75%
3 Month
+18.25%
+18.25%
6 Month
+7.93%
+7.93%
1 Year
+46.42%
+46.42%

More News

Read More
Optimism Building for Advancing Pancreatic Cancer Treatment Therapies
Via FinancialNewsMedia
Exposures Product Safety
Are Tech Layoffs Going to Be a Headache for Alexandria Real Estate Equities?
Via The Motley Fool
Where Bristol-Myers Squibb Stands With Analysts
Via Benzinga
8 Analysts Have This to Say About Bristol-Myers Squibb
Via Benzinga
2 Massive Companies That Have Doubled Their Sales in 5 Years
Via The Motley Fool
Alexandria Real Estate Stock: Bull vs. Bear
Via The Motley Fool
Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Uncertainty Grips Markets-On A Clear Day Maybe You Can See A Week Ahead
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
US Stocks Start Week On Lower Note, Dow Drops Over 100 Points
Via Benzinga
UK Study Finds Pfizer/Bristol Myers Clotting Drug Does Not Help COVID-19 Patients
Via Benzinga
3 Dividend Stocks to Hold Forever
Via The Motley Fool
Is Now the Time for Income Investors to Buy This Big Pharma Stock?
Via The Motley Fool
Mirati Therapeutics Surges As Big Pharma Reportedly Preps For A Buyout Battle
Via Investor's Business Daily
2 Reasons to Buy AbbVie Stock and 1 Reason to Sell
Via The Motley Fool
Southwest Gas, Albemarle, Bristol-Myers Squibb And This Fintech Play On CNBC's 'Final Trades'
Via Benzinga
Gamma Delta T Cell Therapy Market Could Reach $4 Billion As Biotechs Race To Get Breakthrough Cancer Treatment Approved
Via Benzinga
Bristol Myers Squibb Data at ASH 2022 Highlight Innovative Therapeutic Platforms Across a Range of Blood Diseases
From Bristol Myers Squibb
Via Business Wire
Credit Suisse Sees Uncertainty On New Product Launch Execution & Growth For Bristol Myers
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
Via Benzinga
Peering Into Bristol-Myers Squibb's Recent Short Interest
Via Benzinga
2 Stocks to Buy Whether or Not a Recession Is Coming
Via The Motley Fool
OncoSec Touts Encouraging Early Data For Opdivo Combined Immunotherapy For Skin Cancer
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.